According to the Federal Bank of St. Louis, businesses are hiring at one of the slowest rates since 2015.

If you are currently searching for a job, experts recommend tapping into your network as much as possible and celebrating the small wins - even if they’re as small as updating your resume.

Enflonsia, Merck’s medication to treat respiratory syncytial virus (RSV) in infants, has been approved by the FDA. It will now compete with Sanofi and AstraZeneca’s Beyfortus, which was approved by the FDA in July 2023.

No matter your industry, thousands of American workers have been affected by widespread layoffs in 2025.

Stefan Falk, a leadership consultant who studies workplace psychology, has spent more than 30 years helping thousands of individuals and CEOs at multimillion-dollar organizations.

An interesting look at how women can take control of their careers and beat the broken rung - Click here

Life Science Washington has reported that from 2013 to 2023, there has been a 50% job growth. This life sciences cluster has outpaced both national life science growth and private sector growth in Washington.

Sabina Nawas, a former Microsoft HR executive, so many people ‘simply don’t get the basics right.’ Nawas spent 15 years at Microsoft before leaving to start an executive coaching company where she works with senior leaders.

After a patient became ill with a potential drug-induced liver injury, Pfizer announced it would discontinue the development of danuglipron, an orally administered experimental treatment for weight management.

As the workforce rapidly evolves, here is an interesting look at Workforce Trends put together by TI Verbatim Consulting…

People can go to extremes to be taken seriously and earn respect from their peers. Sometimes in doing so they do not sound very smart at all.

LinkedIn has recently posted a Skills on the Rise report showcasing the fastest-growing skills in the US. These skills can help you differentiate yourself among candidates.

Every year there are many prominent exclusivity losses in the pharmaceutical industry but this year’s list has some notable ones.

Number 1 on the list is Johnson & Johnson's Stelara, used to treat Psoriatic arthritis, plaque psoriasis,

This edition of Life Sciences Monthly Pulse from Outcome Capital is packed with in-depth analysis and strategic insights that are shaping the future of the life sciences sector. Their team of experts breaks down the key industry developments you need to know.

In what is described as an ‘always tricky’ Q4, 21 of 22 of the world’s biopharma companies that reported quarterly revenue of at least $2 billion reported an increase in revenue in Q4 of 2024. Leading those increases are Eli Lilly (+45%) and Novo Nordisk (+30%). The only company thus far reporting a decrease is Teva.

GSK’s 5-in-1 meningococcal vaccine, Penmenvy, is designed to protect people ages 10 to 25 against meningococcal serogroups A, B, C, W and Y (MenABCWY), which together cause the most persistent meningococcal disease (IMD) cases globally.

According to a recent survey of 1,824 U.S. adults in white-collar jobs by Harris Poll on behalf of global events company Freeman, 91% of Gen Z workers say they desire a balance between virtual and in-person opportunities. This will allow them to connect with others at their company and in their industry.

In 2024, Evaluate projected that the top 10 expected launches were expected to generate $15.2 billion in sales by 2028. This year’s list is projected to generate nearly double that at $29 billion in annual sales by the end of the decade. This list is the highest projected list in the last five years. One of the primary reasons for the increased figures is a new cystic fibrosis offering from Vertex Pharmaceuticals that tops the list.

Bill Gates has a “favorite book on AI” and thinks everyone should consider reading. The book is titled “The Coming Wave: Technology, Power, and the Twenty-first Century’s Greatest Dilemma” predicts artificial intelligence will change what most jobs look like, across nearly every industry, within the next five years. It is written by AI pioneer Mustafa Suleyman.

Kara Brothers, President of Starface World, likes to assess candidates’ emotional intelligence. During interviews, she relies on tough, introspective questions. She has found one of the best ways to do this is to ask the question, “In your last workplace, what really held you back?” She explains, that the goal is to uncover how adaptable and coachable someone is. Additionally, she feels a person’s self-awareness will translate well to navigating workplace challenges and collaborating with diverse personalities.

According to Emily Levine, who has been working as a recruiter for ultra-high net-worth individuals, celebrities, athletes, and musicians, these are some steps you can take to set yourself up for success in 2025.

1. Make sure your LinkedIn is up to date - First, this moment of quiet in hiring is a good opportunity to clean up your application material.